Alteogen Inc - ESG Rating & Company Profile powered by AI
The article contains a questions and answers table on Alteogen Inc. The assessment of Alteogen Inc employs data from across the internet as well as from available disclosures by Alteogen Inc. Check the bottom of this page for potential risks for Alteogen Inc based on sector, location and size.
Alteogen Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | Alteogen Inc | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Alteogen Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Alteogen Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Alteogen Inc report the average age of the workforce?
Sign up for free to unlockDoes Alteogen Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Alteogen Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Alteogen Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Alteogen Inc offer flexible work?
Sign up for free to unlockDoes Alteogen Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Alteogen Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Alteogen Inc conduct supply chain audits?
Sign up for free to unlockDoes Alteogen Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Alteogen Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Alteogen Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Alteogen Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Alteogen Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Alteogen Inc disclose water use targets?
Sign up for free to unlockDoes Alteogen Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Alteogen Inc have a product recall in the last two years?
Sign up for free to unlockDoes Alteogen Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Alteogen Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Alteogen Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Alteogen Inc disclose parental leave metrics?
Sign up for free to unlockDoes Alteogen Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Alteogen Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Alteogen Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Alteogen Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Alteogen Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Alteogen Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Alteogen Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Alteogen Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Alteogen Inc disclose its waste policy?
Sign up for free to unlockDoes Alteogen Inc report according to TCFD requirements?
Sign up for free to unlockDoes Alteogen Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Alteogen Inc disclose energy use targets?
Sign up for free to unlockDoes Alteogen Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Alteogen Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Alteogen Inc
These potential risks are based on the size, segment and geographies of the company.
ALTEOGEN Inc., a bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars. The company develops ALT-P1, a long-acting human growth hormone that is in the Phase IIa clinical trial; and ALT-Q2, a long-acting active form of coagulation factor VII for the treatment of hemophilia based on its NexP technology. It is also involved in the development of ALT-P7, a targeted breast/gastric cancer drug that is in the Phase I clinical trial; and ALT-Q5, an antibody-drug conjugate (ADC) for the treatment of ovarian cancer based on its NexMab ADC technology. The company has a strategic alliance with Kissei Pharmaceutical to develop Aflibercept that has completed pre-clinical trial; and Cristalia for the development of Trastuzumab, which is in the Phase II clinical trial for the treatment of breast cancer. ALTEOGEN Inc. was founded in 2008 and is headquartered in Daejeon, South Korea.